Urban-rural Differences in Preferences for Traditional Chinese Medicine Services Among Chronic Disease Patients: a Discrete Choice Experiment

Overview

Journal BMC Complement Med Ther

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2024 Oct 14

PMID 39402534

Authors

Fan Jiang

Yuting Feng

Wen Zong

Jianing Xue

Wanning Chen

Liu Qizhi

Jiao Zhang

Aijun Xu

Affiliations

Soon will be listed here.

Abstract

Background: With the increasing prevalence of chronic diseases, the demand for medical services from chronic disease patients has become diversified and personalized. The advantages and role of traditional Chinese medicine in the prevention and treatment of chronic diseases gradually emerging. The preferences and willingness to pay for traditional Chinese medicine services (TCMS) among patients with chronic diseases, as well as any disparities between urban and rural patients, have not been examined in past studies.

Objective: This study aimed to investigate the preferences of chronic disease patients for TCMS, explore the value/importance that patients place on different treatment attributes, and evaluate whether there are urban-rural differences in their preferences and willingness to pay for TCMS.

Methods: A total of 317 patients from Jiangsu Province, China participated in a discrete choice experiment that elicited the preferences for TCMS. The choice questions were constructed by six attributes: out-of-pocket (OOP) cost, institution, medical provider, treatment method, treatment duration, treatment efficacy. Mixed logit models were used to estimate the stated preference and marginal willingness to pay for each attribute.

Results: The choice preferences of chronic disease patients for TCMS in this study were influenced by the four attributes: institution, treatment method, and treatment efficacy, and OOP cost. Improvements in treatment efficacy were the most concerning, followed by being treated in traditional Chinese medicine (TCM) hospital. Patients were willing to pay more to get better treatment outcomes. Compared with primary care institutions, patients were willing to pay more for treatment in TCM hospitals. The preferences for economic attribute (OOP cost) varied between urban and rural areas, and rural patients tended to favor scenarios that imposed a lower economic burden on them.

Conclusion: The chronic disease patients' preferences for TCMS were determined mainly by treatment efficacy but also by institution, treatment method and OOP cost. The urban-rural difference in preference identified in this study highlights that effective policy interventions should consider the characteristics of patients' demand in different regions.

References

Clark M, Determann D, Petrou S, Moro D, de Bekker-Grob E . Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014; 32(9):883-902. DOI: 10.1007/s40273-014-0170-x. View

Meysami M, Hashempur M, Kamalinejad M, Emtiazy M . Efficacy of Short Term Topical Malva Sylvestris L. Cream in Pediatric Patients with Atopic Dermatitis: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Endocr Metab Immune Disord Drug Targets. 2020; 21(9):1673-1678. DOI: 10.2174/1871530320666201023125411. View

Drummond M, Towse A . Orphan drugs policies: a suitable case for treatment. Eur J Health Econ. 2014; 15(4):335-40. DOI: 10.1007/s10198-014-0560-1. View

Reed Johnson F, Lancsar E, Marshall D, Kilambi V, Muhlbacher A, Regier D . Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013; 16(1):3-13. DOI: 10.1016/j.jval.2012.08.2223. View

Lu Z, Zhou Q, Chai S, Yang H, Wang J, Luo H . Efficacy and safety of Chinese medicine combined with acupuncture in the treatment of chronic urticaria: A meta-analysis. Medicine (Baltimore). 2022; 101(36):e30381. PMC: 10980365. DOI: 10.1097/MD.0000000000030381. View

Wang S, Long S, Deng Z, Wu W . Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation. Am J Chin Med. 2020; 48(7):1577-1592. DOI: 10.1142/S0192415X20500780. View

Li Y, Liu Y, Cui J, Zhao H, Liu Y, Huang L . Cohort Studies on Chronic Non-communicable Diseases Treated With Traditional Chinese Medicine: A Bibliometric Analysis. Front Pharmacol. 2021; 12:639860. PMC: 8017211. DOI: 10.3389/fphar.2021.639860. View

Nicolet A, Perraudin C, Wagner J, Gilles I, Krucien N, Peytremann-Bridevaux I . Patient and Public Preferences for Coordinated Care in Switzerland: Development of a Discrete Choice Experiment. Patient. 2022; 15(4):485-496. PMC: 9197802. DOI: 10.1007/s40271-021-00568-2. View

Carman W, Ishida M, Trounson J, Mercer S, Anindya K, Sum G . Epidemiology of physical-mental multimorbidity and its impact among Aboriginal and Torres Strait Islander in Australia: a cross-sectional analysis of a nationally representative sample. BMJ Open. 2022; 12(10):e054999. PMC: 9557280. DOI: 10.1136/bmjopen-2021-054999. View

10.

Quinaz Romana G, Kislaya I, Cunha Goncalves S, Salvador M, Nunes B, Matias Dias C . Healthcare use in patients with multimorbidity. Eur J Public Health. 2020; 30(1):16-22. DOI: 10.1093/eurpub/ckz118. View

11.

Liu J, Yin H, Zheng T, Ilia B, Wang X, Chen R . Primary health institutions preference by hypertensive patients: effect of distance, trust and quality of management in the rural Heilongjiang province of China. BMC Health Serv Res. 2019; 19(1):852. PMC: 6868842. DOI: 10.1186/s12913-019-4465-7. View

12.

Lopez-Bastida J, Ramos-Goni J, Aranda-Reneo I, Taruscio D, Magrelli A, Kanavos P . Using a stated preference discrete choice experiment to assess societal value from the perspective of patients with rare diseases in Italy. Orphanet J Rare Dis. 2019; 14(1):154. PMC: 6595697. DOI: 10.1186/s13023-019-1126-1. View

13.

Telser H, Zweifel P . Measuring willingness-to-pay for risk reduction: an application of conjoint analysis. Health Econ. 2002; 11(2):129-39. DOI: 10.1002/hec.653. View

14.

Fradgley E, Paul C, Bryant J, Oldmeadow C . Getting right to the point: identifying Australian outpatients' priorities and preferences for patient-centred quality improvement in chronic disease care. Int J Qual Health Care. 2016; 28(4):470-7. DOI: 10.1093/intqhc/mzw049. View

15.

Zhu J, Li J, Zhang Z, Li H, Cai L . Exploring determinants of health provider choice and heterogeneity in preference among outpatients in Beijing: a labelled discrete choice experiment. BMJ Open. 2019; 9(4):e023363. PMC: 6500246. DOI: 10.1136/bmjopen-2018-023363. View

16.

Fang M, Wang D, Coresh J, Selvin E . Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018. N Engl J Med. 2021; 384(23):2219-2228. PMC: 8385648. DOI: 10.1056/NEJMsa2032271. View

17.

Lv Y, Fu Q, Shen X, Jia E, Li X, Peng Y . Treatment Preferences of Residents Assumed to Have Severe Chronic Diseases in China: A Discrete Choice Experiment. Int J Environ Res Public Health. 2020; 17(22). PMC: 7697856. DOI: 10.3390/ijerph17228420. View

18.

Mozaffarian D . Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. Circulation. 2016; 133(2):187-225. PMC: 4814348. DOI: 10.1161/CIRCULATIONAHA.115.018585. View

19.

Wang Y, Feng J, Zhang J, Shen X, Lei Z, Zhu Y . Willingness to seek medical care for tuberculosis and associated factors among the elderly population in Shenzhen: a cross-sectional study. BMJ Open. 2021; 11(9):e051291. PMC: 8458307. DOI: 10.1136/bmjopen-2021-051291. View

20.

Li X, Krumholz H, Yip W, Cheng K, De Maeseneer J, Meng Q . Quality of primary health care in China: challenges and recommendations. Lancet. 2020; 395(10239):1802-1812. PMC: 7272159. DOI: 10.1016/S0140-6736(20)30122-7. View